Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Travere Therapeutics, Inc. (RTRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "Travere Therapeutics Reports Second Quarter 2023 Financial Results"
07/17/2023 8-K Quarterly results
05/31/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
05/04/2023 8-K Quarterly results
Docs: "Travere Therapeutics Reports First Quarter 2023 Financial Results FILSPARI™ granted accelerated approval by FDA for the reduction of proteinuria in IgA nephropathy on February 17th, 2023&#59; commercial launch underway"
05/01/2023 8-K Quarterly results
03/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, by and among Travere Therapeutics, Inc., Jefferies LLC, J.P. Morgan Securities LLC, BofA Securities, Inc. and SVB Securities LLC",
"Form of Pre-Funded Warrant",
"Opinion of Cooley LLP",
"Travere Therapeutics Announces Proposed Public Offering of Common Stock",
"Travere Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants"
01/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Travere Therapeutics Provides Corporate Update and 2023 Outlook"
10/27/2022 8-K Quarterly results
10/13/2022 8-K Other Events  Interactive Data
08/22/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/20/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Travere Therapeutics, Inc. 3611 Valley Centre Drive, Suite 300"
03/21/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
03/11/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
01/10/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Travere Therapeutics Provides Corporate Update and 2022 Outlook"
01/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CONSULTING SERVICES AGREEMENT"
12/22/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
12/15/2021 8-K Quarterly results
10/28/2021 8-K Quarterly results
Docs: "Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress"
10/12/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Transition Agreement"
09/16/2021 8-K Quarterly results
09/15/2021 8-K Quarterly results
09/14/2021 8-K Quarterly results
09/07/2021 8-K Quarterly results
08/16/2021 8-K Quarterly results
07/29/2021 8-K Quarterly results
Docs: "Travere Therapeutics Reports Second Quarter 2021 Financial Results"
06/10/2021 8-K Quarterly results
05/25/2021 8-K Quarterly results
05/18/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy